Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates

Sarcopenia, or loss of skeletal muscle mass, is associated with increased mortality and morbidity in liver transplant (LT) candidates. Six‐minute walk distance (6MWD) and health‐related quality of life (HRQOL) as assessed by short form 36 scores (SF‐36) also impact clinical outcomes in these patient...

Full description

Saved in:
Bibliographic Details
Published in:Clinical transplantation 2015-02, Vol.29 (2), p.134-141
Main Authors: Yadav, Anitha, Chang, Yu-Hui, Carpenter, Sarah, Silva, Alvin C., Rakela, Jorge, Aqel, Bashar A., Byrne, Thomas J., Douglas, David D., Vargas, Hugo E., Carey, Elizabeth J.
Format: Article
Language:English
Subjects:
Body Mass Index
Exercise Test
Female
functional capacity
gait speed
Humans
Liver Transplantation - psychology
Male
Middle Aged
muscle mass
Prognosis
prognostic factor
Quality of Life
Retrospective Studies
Sarcopenia - physiopathology
Sarcopenia - psychology
short form-36 scores
Transplants
Walking - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sarcopenia, or loss of skeletal muscle mass, is associated with increased mortality and morbidity in liver transplant (LT) candidates. Six‐minute walk distance (6MWD) and health‐related quality of life (HRQOL) as assessed by short form 36 scores (SF‐36) also impact clinical outcomes in these patients. This study explored the relationship between the sarcopenia, 6MWD, and HRQOL in LT candidates. Sarcopenia was evaluated based on skeletal muscle mass index (SMI) quantified from abdominal computed tomography. Patients were followed until death, removal from the wait list or the end of the study period. Two hundred and thirteen patients listed for LT were included. The mean SMI, 6MWD and mean gait speed were 54.3 ± 9.7, 370.5 m and 1 m/s, respectively. Sarcopenia was noted in 22.2% of LT candidates. There was no correlation between sarcopenia, 6MWD, and SF‐36 scores. The 6MWD, but not sarcopenia, was an independent predictor of mortality (hazard ratio = 2.1 [0.9–4.7]). In summary, sarcopenia did not emerge as a significant predictor of waitlist mortality and also failed to correlate with either functional capacity or HRQOL in LT candidates. In patients with ESLD awaiting LT, 6MWD appears to be a more useful prognostic indicator than the presence of sarcopenia.
ISSN:0902-0063
1399-0012
DOI:10.1111/ctr.12493